Michel Goldman | Academic Influence

Michel Goldman's AcademicInfluence.com Rankings

Michel Goldman

Biology

#4172

World Rank

#6262

Historical Rank

Immunology

#224

World Rank

#233

Historical Rank

biology Degrees

Michel Goldman

Philosophy

#5015

World Rank

#7719

Historical Rank

Logic

#2365

World Rank

#3344

Historical Rank

philosophy Degrees

Download Badge

Biology
Philosophy

Michel Goldman's Degrees

Doctorate Medicine Université libre de Bruxelles
PhD Immunology Université libre de Bruxelles

Why Is Michel Goldman Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Michel Goldman is a Belgian medical doctor who specialized in internal medicine and immunology. Biography Michel Goldman graduated as a medical doctor from Université Libre de Bruxelles , Belgium, and received his PhD in medical sciences from Université de Genève, Switzerland. He is board certified in internal medicine and clinical biology .

(See a Problem?)

Michel Goldman's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. (2005) (909)
Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia (1993) (863)
Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. (2010) (497)
Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: evidence for a soluble CD14-dependent pathway. (1997) (491)
Interleukin-10 (2012) (486)
Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. (1997) (440)
Interleukin‐10 inhibits B7 and intercellular adhesion molecule‐1 expression on human monocytes (1994) (411)
TH2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically-induced autoimmunity. (1991) (384)
Interleukin-10 production during septicaemia (1994) (375)
Deficient IL-12(p35) Gene Expression by Dendritic Cells Derived from Neonatal Monocytes1 (2001) (363)
IL-10 Is an Important Mediator of the Enhanced Susceptibility to Pneumococcal Pneumonia after Influenza Infection (2004) (361)
RELEASE OF TUMOR NECROSIS FACTOR, INTERLEUKIN‐2, AND GAMMA‐INTERFERON IN SERUM AFTER INJECTION OF OKT3 MONOCLONAL ANTIBODY IN KIDNEY TRANSPLANT RECIPIENTS (1989) (346)
Interleukin‐10 controls interferon‐γ and tumor necrosis factor production during experimental endotoxemia (1994) (328)
Brief report: clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome. (1994) (327)
Vaccination and autoimmune disease: what is the evidence? (2003) (317)
Interleukin‐10 differentially regulates B7‐1 (CD80) and B7‐2 (CD86) expression on human peripheral blood dendritic cells (1995) (301)
Endogenous IL-10 protects mice from death during septic peritonitis. (1995) (299)
Interleukin-10 impairs host defense in murine pneumococcal pneumonia. (1996) (293)
Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion (1994) (292)
Interleukin‐10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin‐4 and granulocyte/ macrophage‐colony‐stimulating factor (1997) (260)
Interleukin‐10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice (1998) (253)
B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10. (1994) (252)
Human dendritic cell responses to lipopolysaccharide and CD40 ligation are differentially regulated by interleukin‐10 (1997) (231)
Multiple pathways to allograft rejection (2002) (225)
N-Acetyl-l-Cysteine Inhibits Primary Human T Cell Responses at the Dendritic Cell Level: Association with NF-κB Inhibition (1999) (224)
Interleukin 10 prevents necrosis in murine experimental acute pancreatitis. (1995) (223)
Cytokine mRNA quantification by real-time PCR. (2002) (222)
Hypereosinophilic syndromes (2007) (212)
TH2 activated cells prevent experimental autoimmune uveoretinitis, a TH1‐dependent autoimmune disease (1993) (193)
T cell‐mediated immune responses in human newborns: ready to learn? (2005) (190)
Clonal Th2 lymphocytes in patients with the idiopathic hypereosinophilic syndrome (2000) (189)
Interleukin‐10 modulates susceptibility in experimental cerebral malaria (1997) (189)
Spleen cell cytokine secretion in Mycobacterium bovis BCG-infected mice (1992) (187)
Production and role of interleukin‐10 in concanavalin A–induced hepatitis in mice (1997) (186)
Heterogeneous T cell responses to beta-lactam-modified self-structures are observed in penicillin-allergic individuals. (1995) (184)
Human cytokine responses to cardiac transplantation and coronary artery bypass grafting. (1996) (184)
Monophosphoryl Lipid A Activates Both Human Dendritic Cells and T Cells1 (2002) (184)
Adenosine enhances IL-10 secretion by human monocytes. (1996) (183)
Blood plasmacytoid dendritic cell responses to CpG oligodeoxynucleotides are impaired in human newborns. (2004) (183)
A Defect in Nucleosome Remodeling Prevents IL-12(p35) Gene Transcription in Neonatal Dendritic Cells (2004) (182)
How microorganisms tip the balance between interleukin-12 family members (2008) (180)
Double-stranded RNAs from the Helminth Parasite Schistosoma Activate TLR3 in Dendritic Cells* (2005) (176)
Anaphylactoid reactions during hemodialysis on AN69 membranes in patients receiving ACE inhibitors. (1990) (171)
IL-10: a potential therapy for allergic inflammation? (1997) (170)
Human cytomegalovirus elicits fetal γδ T cell responses in utero (2010) (169)
IL-27 Synthesis Induced by TLR Ligation Critically Depends on IFN Regulatory Factor 31 (2007) (167)
Impaired responses to toll-like receptor 4 and toll-like receptor 3 ligands in human cord blood. (2003) (164)
The protective role of endogenously synthesized nitric oxide in staphylococcal enterotoxin B-induced shock in mice (1994) (163)
Human γδ T Cells Induce Dendritic Cell Maturation (2002) (158)
Lymphocytic variant hypereosinophilic syndromes. (2007) (157)
Endotoxin‐Induced Myeloid‐Derived Suppressor Cells Inhibit Alloimmune Responses via Heme Oxygenase‐1 (2009) (155)
Neonatal bacillus Calmette‐Guérin vaccination induces adult‐like IFN‐γ production by CD4+ T lymphocytes (2001) (153)
Recombinant interferon-alpha selectively inhibits the production of interleukin-5 by human CD4+ T cells. (1996) (151)
Recent advances in pathogenesis and management of hypereosinophilic syndromes (2004) (151)
Inflammation modifies the pattern and the function of Toll-like receptors expressed by human mesenchymal stromal cells. (2010) (151)
IL‐23 up‐regulates IL‐10 and induces IL‐17 synthesis by polyclonally activated naive T cells in human (2005) (151)
Induction of FOXP3‐expressing regulatory CD4pos T cells by human mature autologous dendritic cells (2004) (148)
The injection of deaggregated gamma globulins in adult mice induces antigen-specific unresponsiveness of T helper type 1 but not type 2 lymphocytes (1992) (142)
Systemic release and protective role of IL-10 in staphylococcal enterotoxin B-induced shock in mice. (1994) (142)
High levels of interleukin-10 during the initial phase of fulminant meningococcal septic shock. (1995) (141)
Acquisition of Adult-Like TLR4 and TLR9 Responses during the First Year of Life (2010) (140)
Basophil activation tests for the diagnosis of food allergy in children (2009) (139)
The hypereosinophilic syndrome revisited. (2003) (136)
Nicotine Protects Kidney from Renal Ischemia/Reperfusion Injury through the Cholinergic Anti-Inflammatory Pathway (2007) (135)
Inhibition of phosphoinositide 3‐kinase enhances TRIF‐dependent NF‐κB activation and IFN‐β synthesis downstream of Toll‐like receptor 3 and 4 (2005) (134)
Trypanosoma cruzi Infects Human Dendritic Cells and Prevents Their Maturation: Inhibition of Cytokines, HLA-DR, And Costimulatory Molecules (1999) (131)
Differential effects of pentoxifylline on the production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) by monocytes and T cells. (1992) (130)
Subclavian vein thrombosis: a frequent complication of subclavian vein cannulation for hemodialysis. (1986) (130)
In vivo induction of interleukin 10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: differential modulation by cyclosporin A (1993) (129)
Interferon regulatory factor 3 is involved in Toll-like receptor 4 (TLR4)- and TLR3-induced IL-12p35 gene activation. (2006) (129)
Preferential production of the IL‐12(p40)/IL‐23(p19) heterodimer by dendritic cells from human newborns (2006) (125)
Expression of c-FLIP(L) and resistance to CD95-mediated apoptosis of monocyte-derived dendritic cells: inhibition by bisindolylmaleimide. (2000) (125)
Hepatoprotective role of interleukin 10 in galactosamine/lipopolysaccharide mouse liver injury. (1997) (124)
Myocardial Homing of Nonmobilized Peripheral‐Blood CD34+ Cells After Intracoronary Injection (2006) (124)
Role of defective monocyte interleukin‐10 release in tumor necrosis factor‐alpha overproduction in alcoholic cirrhosis (1995) (122)
Critical roles for IL-4, IL-5, and eosinophils in chronic skin allograft rejection. (1999) (122)
Blood interleukin 10 levels parallel the severity of septic shock. (1997) (121)
Cold liver ischemia‐reperfusion injury critically depends on liver T cells and is improved by donor pretreatment with interleukin 10 in mice (2000) (119)
A role for eosinophils in transplant rejection. (2001) (113)
Extracellular adenine nucleotides modulate cytokine production by human monocyte‐derived dendritic cells: dual effect on IL‐12 and stimulation of IL‐10 (2002) (109)
Neonatal bacillus Calmette-Guérin vaccination induces adult-like IFN-gamma production by CD4+ T lymphocytes. (2001) (108)
Predominance of type 1 CD4+T cells in human abdominal aortic aneurysm (2005) (106)
Lipopolysaccharide induces up‐regulation of CD14 molecule on monocytes in human whole blood (1992) (106)
Interleukin‐10 inhibits the induction of monocyte procoagulant activity by bacterial lipopolysaccharide (1993) (106)
Double-Stranded RNA Induces Pancreatic β-Cell Apoptosis by Activation of the Toll-Like Receptor 3 and Interferon Regulatory Factor 3 Pathways (2008) (104)
CRITICAL ROLE OF INTERLEUKIN 4 IN THE INDUCTION OF NEONATAL TRANSPLANTATION TOLERANCE (1995) (103)
Spontaneous secretion of interferon γ and interleukin 4 by human intraepithelial and lamina propria gut lymphocytes (1998) (103)
Incidence of histoplasmosis following allogeneic bone marrow transplant or solid organ transplant in a hyperendemic area (2002) (99)
Mepolizumab as a corticosteroid-sparing agent in lymphocytic variant hypereosinophilic syndrome. (2010) (98)
Complications related to subclavian catheters for hemodialysis. Report and review. (1986) (97)
Interferon regulatory factor 7‐mediated responses are defective in cord blood plasmacytoid dendritic cells (2008) (96)
Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock (1995) (95)
Interferon regulatory factor 3-dependent responses to lipopolysaccharide are selectively blunted in cord blood cells. (2007) (95)
Inhibition of human dendritic cell functions by methylprednisolone. (1999) (95)
Induction of thromboses within renal grafts by high-dose prophylactic OKT3 (1992) (95)
Interleukin-10 as a regulatory cytokine induced by cellular stress: molecular aspects. (1998) (94)
The Innovative Medicines Initiative: A European Response to the Innovation Challenge (2012) (94)
Preparing for a responsible lockdown exit strategy (2020) (93)
T helper type 2‐like cells and therapeutic effects of interferon‐γ in combined immunodeficiency with hypereosinophilia (Omenn's syndrome) (1993) (93)
Early inflammatory response after elective abdominal aortic aneurysm repair: a comparison between endovascular procedure and conventional surgery. (2000) (92)
Critical Role of the IFN-Stimulated Gene Factor 3 Complex in TLR-Mediated IL-27p28 Gene Expression Revealing a Two-Step Activation Process (2010) (91)
Critical Influence of Natural Regulatory CD25+ T Cells on the Fate of Allografts in the Absence of Immunosuppression (2005) (91)
High serum thymus and activation-regulated chemokine levels in the lymphocytic variant of the hypereosinophilic syndrome. (2002) (90)
Hypothermia and hypoglycemia induced by anti‐CD3 monoclonal antibody in mice: Role of tumor necrosis factor (1990) (89)
Protein kinase C epsilon: a new target to control inflammation and immune-mediated disorders. (2004) (89)
DiC14‐amidine cationic liposomes stimulate myeloid dendritic cells through Toll‐like receptor 4 (2008) (89)
Loss of tumorigenicity and increased immunogenicity induced by interleukin-10 gene transfer in B16 melanoma cells. (1996) (89)
Intraperitoneal secretion of interleukin-6 during continuous ambulatory peritoneal dialysis. (1990) (88)
Eosinophils express a functional receptor for interferon alpha: inhibitory role of interferon alpha on the release of mediators. (1996) (87)
Thrombospondin-1 and indoleamine 2,3-dioxygenase are major targets of extracellular ATP in human dendritic cells. (2005) (85)
Interleukin-6: an early marker of bacterial infection in decompensated cirrhosis. (1994) (83)
Interleukin-3 and interferon beta cooperate to induce differentiation of monocytes into dendritic cells with potent helper T-cell stimulatory properties. (2002) (83)
Effects of ultrapure and non-sterile dialysate on the inflammatory response during in vitro hemodialysis. (1996) (81)
Acute Rejection in the Absence of Cognate Recognition of Allograft by T Cells1 (2001) (80)
Human gamma delta T cells induce dendritic cell maturation. (2002) (78)
The multiple facets of toll-like receptors in transplantation biology. (2008) (78)
Bordetella pertussis toxin induces the release of inflammatory cytokines and dendritic cell activation in whole blood: impaired responses in human newborns (2002) (77)
Remission and immune reconstitution after T-cell-depleted stem-cell transplantation for rheumatoid arthritis (1998) (76)
Anaphylactic shock caused by immunoglobulin E sensitization after retreatment with the chimeric anti–interleukin-2 receptor monoclonal antibody basiliximab (2003) (74)
Systemic release of interleukin‐10 during orthotopic liver transplantation (1994) (73)
T-cell receptor-independent activation of clonal Th2 cells associated with chronic hypereosinophilia. (1999) (73)
Anaphylactic shock after retreatment with OKT3 monoclonal antibody. (1992) (72)
EVIDENCE THAT PENTOXIFYLLINE REDUCES ANTI‐CD3 MONOCLONAL ANTIBODY‐INDUCED CYTOKINE RELEASE SYNDROME (1991) (72)
CD40 ligation prevents neonatal induction of transplantation tolerance. (1998) (71)
Critical role of interleukin 5 and eosinophils in concanavalin A-induced hepatitis in mice. (2002) (71)
Immune monitoring in whole blood using real-time PCR. (2003) (70)
N-acetyl-L-cysteine inhibits primary human T cell responses at the dendritic cell level: association with NF-kappaB inhibition. (1999) (70)
Tumoricidal Activity of Monocyte-Derived Dendritic Cells: Evidence for a Caspase-8-Dependent, Fas-Associated Death Domain-Independent Mechanism1 (2001) (70)
A Critical Role for p53 in the Control of NF-κB-Dependent Gene Expression in TLR4-Stimulated Dendritic Cells Exposed to Genistein1 (2007) (70)
Role of reactive oxygen intermediates in interleukin 10 release after cold liver ischemia and reperfusion in mice. (1997) (69)
Early immunosuppression withdrawal after living donor liver transplantation and donor stem cell infusion (2006) (69)
Antigen-Specific Central Memory CD4+ T Lymphocytes Produce Multiple Cytokines and Proliferate In Vivo in Humans1 (2006) (69)
Tissue factor‐dependent procoagulant activity of isolated human hepatocytes: Relevance to liver cell transplantation (2007) (69)
Cellular mechanisms underlying acute graft rejection: time for reassessment. (2007) (69)
Clinical characteristics of 13 solid organ transplant recipients with ganciclovir‐resistant cytomegalovirus infection (2002) (68)
Chlorpromazine specifically inhibits peripheral and brain TNF production, and up-regulates IL-10 production, in mice. (1994) (66)
THE LONG‐TERM EFFECTS OF PROPHYLACTIC OKT3 MONOCLONAL ANTIBODY IN CADAVER KIDNEY TRANSPLANTATION—A SINGLE‐CENTER, PROSPECTIVE, RANDOMIZED STUDY (1992) (66)
IL‐23R and TCR signaling drives the generation of neonatal Vγ9Vδ2 T cells expressing high levels of cytotoxic mediators and producing IFN‐γ and IL‐17 (2011) (64)
A new dendritic cell vaccine generated with interleukin-3 and interferon-β induces CD8+ T cell responses against NA17-A2 tumor peptide in melanoma patients (2006) (63)
IL-5 mediates eosinophilic rejection of MHC class II-disparate skin allografts in mice. (1999) (62)
Impairment of phagocyte oxidative metabolism in hemodialyzed patients with iron overload. (1986) (62)
Modulation of liver injury by interleukin-10. (2003) (62)
Critical Role of Regulatory T Cells in Th17-Mediated Minor Antigen-Disparate Rejection (2010) (62)
IL‐5 and eosinophils mediate the rejection of fully histoincompatible vascularized cardiac allografts: regulatory role of alloreactive CD8+ T lymphocytes and IFN‐γ (2000) (61)
Transient expansion of peptide‐specific lymphocytes producing IFN‐γ after vaccination with dendritic cells pulsed with MAGE peptides in patients with mage‐A1/A3‐positive tumors (2001) (60)
Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft. (2004) (60)
Mesangial cell-derived interleukin-10 modulates mesangial cell response to lipopolysaccharide. (1995) (60)
IL‐12 prevents neonatal induction of transplantation tolerance in mice (1998) (59)
Steroid administration in heart and heart-lung transplantation: is the timing adequate? (1996) (59)
Interleukin-12 family members and the balance between rejection and tolerance (2008) (59)
Extracellular Adenine Nucleotides Inhibit the Activation of Human CD4+ T Lymphocytes1 (2002) (59)
IFN-beta interferes with the differentiation of dendritic cells from peripheral blood mononuclear cells: selective inhibition of CD40-dependent interleukin-12 secretion. (1999) (58)
A cascade of cytokines is responsible for IL-9 expression in human T cells. Involvement of IL-2, IL-4, and IL-10. (1995) (58)
Increased production of interleukin-10 and interleukin-1 receptor antagonist after extracorporeal photochemotherapy in chronic graft-versus-host disease1 (2002) (57)
111In-oxine and 99mTc-HMPAO labelling of antigen-loaded dendritic cells: in vivo imaging and influence on motility and actin content (2003) (56)
A pilot trial of recombinant human interleukin-10 in kidney transplant recipients receiving OKT3 induction therapy. (1997) (55)
Hyper IgE in stimulatory graft‐ versus‐host disease: role of interleukin‐4 (1991) (55)
Adhesion molecules and leukocyte common antigen on monocytes and granulocytes during hemodialysis. (1993) (55)
Adsorption of ß2-Microglobulin on Dialysis Membranes: Comparison of Different Dialyzers and Effects of Reuse Procedures (1989) (55)
Consensus statement regarding OKT3-induced cytokine-release syndrome and human antimouse antibodies. (1993) (54)
Human IL-12(p35) gene activation involves selective remodeling of a single nucleosome within a region of the promoter containing critical Sp1-binding sites. (2003) (54)
Interferon α prevents spontaneous apoptosis of clonal Th2 cells associated with chronic hypereosinophilia (2000) (54)
Critical role of protein kinase C ϵ for lipopolysaccharide‐induced IL‐12 synthesis in monocyte‐derived dendritic cells (2002) (54)
Trypanosoma cruzi down-regulates lipopolysaccharide-induced MHC class I on human dendritic cells and impairs antigen presentation to specific CD8(+) T lymphocytes. (2002) (54)
CD4+CD25+ and CD4+CD25− T Cells Act Respectively as Inducer and Effector T Suppressor Cells in Superantigen-Induced Tolerance1 (2003) (53)
Fake News or Weak Science? Visibility and Characterization of Antivaccine Webpages Returned by Google in Different Languages and Countries (2018) (53)
The vasoactive intestinal peptide analogue RO25-1553 inhibits the production of TNF and IL-12 by LPS-activated monocytes. (1998) (53)
CD40 Ligation Prevents Trypanosoma cruziInfection through Interleukin-12 Upregulation (1999) (52)
IL‐12 and type I IFN response of neonatal myeloid DC to human CMV infection (2009) (52)
Repeated concanavalin a challenge in mice induces an interleukin 10–producing phenotype and liver fibrosis (2000) (52)
Human monocyte-derived dendritic cells produce bioactive gelatinase B: inhibition by IFN-beta. (2001) (52)
Methylprednisolone differentially regulates IL‐10 and tumour necrosis factor (TNF) production during murine endotoxaemia (1996) (51)
Infections associated with subclavian dialysis catheters: the key role of nurse training. (1986) (51)
The Interleukin‐12 Family: New Players in Transplantation Immunity? (2007) (51)
Chronic exposure to superantigen induces regulatory CD4(+) T cells with IL-10-mediated suppressive activity. (2001) (50)
IL‐12 inhibits in vitro immunoglobulin production by human lupus peripheral blood mononuclear cells (PBMC) (1997) (50)
PKC‐α controls MYD88‐dependent TLR/IL‐1R signaling and cytokine production in mouse and human dendritic cells (2010) (49)
Differential effect of human immunodeficiency virus infection on the IgA and IgG antibody responses to pneumococcal vaccine. (1995) (48)
Dendritic cells overexpressing CD95 (Fas) ligand elicit vigorous allospecific T-cell responses in vivo. (2003) (48)
Faculty Opinions recommendation of The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. (2008) (48)
lnterleukin-10 Inhibits Lipopolysaccharide-Induced Tumor Necrosis Factor and Interleukin-1β Production in the Brain without Affecting the Activation of the Hypothalamus-Pituitary-Adrenal Axis (1995) (48)
6q- is an early and persistent chromosomal aberration in CD3-CD4+ T-cell clones associated with the lymphocytic variant of hypereosinophilic syndrome. (2005) (48)
The Innovative Medicines Initiative: an engine for regulatory science (2014) (48)
Hypereosinophilic syndrome: lymphoproliferative and myeloproliferative variants. (2006) (48)
CD40 engagement induces monocyte procoagulant activity through an interleukin‐10 resistant pathway (1996) (47)
IL‐10 up‐regulates nitric oxide (NO) synthesis by lipopolysaccharide (LPS)‐activated macrophages: improved control of Trypanosoma cruzi infection (1998) (47)
Antiinflammatory properties of mycophenolate mofetil in murine endotoxemia: inhibition of TNF-alpha and upregulation of IL-10 release. (1999) (47)
In vivo T cell activation by anti-CD3 monoclonal antibody induces soluble TNF receptor release in mice. Effects of pentoxifylline, methylprednisolone, anti-TNF, and anti-IFN-gamma antibodies. (1994) (47)
OKT3 prophylaxis in renal grafts with prolonged cold ischemia times: association with improvement in long-term survival. (1996) (47)
Human pancreatic duct cells exert tissue factor-dependent procoagulant activity: relevance to islet transplantation. (2004) (46)
Deposition of idiotype-anti-idiotype immune complexes in renal glomeruli after polyclonal B cell activation (1982) (46)
IFN-gamma prevents Th2 cell-mediated pathology after neonatal injection of semiallogenic spleen cells in mice. (1994) (45)
Protective effect of a single interleukin-12 (IL-12) predose against the toxicity of subsequent chronic IL-12 in mice: role of cytokines and glucocorticoids. (1997) (41)
Interferon response factor 3 is essential for house dust mite-induced airway allergy. (2010) (41)
Dendritic cells exposed to nacystelyn are refractory to maturation and promote the emergence of alloreactive regulatory T cells (2003) (40)
Deficiency of alpha7 cholinergic receptors facilitates bacterial clearance in Escherichia coli peritonitis. (2008) (40)
Increased expression of class II major histocompatibility complex molecules on B cells in rats susceptible or resistant to HgC12‐induced autoimmunity (1991) (40)
MODULATION OF THE RELEASE OF CYTOKINES AND REDUCTION OF THE SHOCK SYNDROME INDUCED BY ANTI‐CD3 MONOCLONAL ANTIBODY IN MICE BY INTERLEUKIN‐10 (1994) (40)
Autoimmunity and immune complex disease after neonatal induction of transplantation tolerance in mice. (1983) (39)
Alteration of Migration and Maturation of Dendritic Cells and T-Cell Depletion in the Course of Experimental Trypanosoma cruzi Infection (2003) (39)
Administration of an antibody to E-selectin in patients with septic shock. (1996) (39)
IL-4 Deficiency Prevents Eosinophilic Rejection and Uncovers a Role for Neutrophils in the Rejection of MHC Class II Disparate Skin Grafts (2005) (39)
Persistent production of TH2-type cytokines and polyclonal B cell activation after chronic administration of staphylococcal enterotoxin B in mice. (1996) (39)
Expansion of Memory-Type CD8+ T Cells Correlates With the Failure of Early Immunosuppression Withdrawal After Cadaver Liver Transplantation Using High-Dose ATG Induction and Rapamycin (2013) (38)
Helper T-cell responses elicited by Der p 1-pulsed dendritic cells and recombinant IL-12 in atopic and healthy subjects. (2000) (38)
Translational Mini‐Review Series on Toll‐like Receptors: Toll‐like receptor ligands as novel pharmaceuticals for allergic disorders (2007) (38)
CD40 expression on human pancreatic duct cells: role in nuclear factor-kappa B activation and production of pro-inflammatory cytokines (2004) (38)
From tolerance to autoimmunity: is there a risk in early life vaccination? (2007) (37)
Synthesis of cytokines by eosinophils and their regulation. (1995) (37)
Molecular profiling of CD3-CD4+ T cells from patients with the lymphocytic variant of hypereosinophilic syndrome reveals targeting of growth control pathways. (2009) (37)
Procoagulant effect of the OKT3 monoclonal antibody: involvement of tumor necrosis factor. (1992) (37)
Bone marrow-derived immature dendritic cells prime in vivo alloreactive T cells for interleukin-4-dependent rejection of major histocompatibility complex class II antigen-disparate cardiac allograft. (2003) (37)
Thrombotic thrombocytopenia associated with COVID-19 infection or vaccination: Possible paths to platelet factor 4 autoimmunity (2021) (37)
Reflections on the Innovative Medicines Initiative (2011) (37)
Interferon alpha prevents spontaneous apoptosis of clonal Th2 cells associated with chronic hypereosinophilia. (2000) (36)
Interferon regulatory factor 3 deficiency leads to interleukin‐17‐mediated liver ischemia‐reperfusion injury (2013) (36)
Interferon-beta inhibits Th1 responses at the dendritic cell level. Relevance to multiple sclerosis. (1999) (36)
Autoantibodies and SARS-CoV2 infection: The spectrum from association to clinical implication: Report of the 15th Dresden Symposium on Autoantibodies (2021) (36)
Neonatal induction of transplantation tolerance in mice is associated with in vivo expression of IL-4 and -10 mRNAs. (1993) (36)
Persistence of anti‐donor allohelper T cells after neonatal induction of allotolerance in mice (1990) (36)
Anti-CD3 antibodies induce T cells from unprimed animals to secrete IL-4 both in vitro and in vivo. (1990) (36)
Continuous ambulatory peritoneal dialysis vs haemodialysis: a lesser risk of amyloidosis? (1988) (36)
Enzymatic degradation of tumor necrosis factor by activated human neutrophils: role of elastase. (1991) (35)
Polyclonal activation and experimental nephropathies. (1988) (35)
Public-private partnerships as driving forces in the quest for innovative medicines (2013) (35)
Impaired phagocyte responses to lipopolysaccharide in paroxysmal nocturnal hemoglobinuria (1993) (35)
Characterization of a subset of antigen‐specific human central memory CD4+ T lymphocytes producing effector cytokines (2008) (35)
Non‐Classical Pathways of Cell‐Mediated Allograft Rejection: New Challenges for Tolerance Induction? (2003) (34)
Bacterial infections in chronic hemodialysis patients: epidemiologic and pathophysiologic aspects. (1990) (34)
Cyclosporine A Drives a Th17‐ and Th2‐Mediated Posttransplant Obliterative Airway Disease (2013) (33)
Upregulation of adhesion molecules induced by broncho-vaxom on phagocytic cells. (1992) (33)
OKT3-INDUCED CYTOKINE RELEASE ATTENUATION BY HIGH-DOSE METHYLPREDNISOLONE (1989) (33)
Tolerance induction in clinical transplantation: the pending questions (2003) (32)
Analysis of the peripheral T‐cell repertoire in kidney transplant patients (2010) (32)
TARC and IL-5 expression correlates with tissue eosinophilia in peripheral T-cell lymphomas. (2008) (31)
Detection of blood chimerism after lung and heart-lung transplantation. The superiority of nested as compared with standard polymerase chain reaction amplification. (1994) (31)
Free cationic liposomes inhibit the inflammatory response to cationic lipid-DNA complex injected intravenously and enhance its transfection efficiency. (2003) (31)
Post-transplantation lymphoproliferative disorder and OKT3. (1991) (31)
Interleukin-9 promotes eosinophilic rejection of mouse heart allografts (2003) (31)
The fate of dendritic cells in a mouse model of liver ischemia/reperfusion injury. (2004) (30)
Protein Kinase Cα Is Involved in Interferon Regulatory Factor 3 Activation and Type I Interferon-β Synthesis* (2007) (30)
DENDRITIC CELLS TRANSDUCED WITH VIRAL INTERLEUKIN 10 OR FAS LIGAND: NO EVIDENCE FOR INDUCTION OF ALLOTOLERANCE IN VIVO (2002) (30)
Inhibition of the CD40 pathway of monocyte activation by triazolopyrimidine. (1999) (30)
Increased serum levels of endopeptidase 24.11 ('enkephalinase') in patients with end-stage renal failure. (1989) (29)
Clonal Th2 cells associated with chronic hypereosinophilia: TARC‐induced CCR4 down‐regulation in vivo (2001) (29)
The production of anti-idiotypic antibodies and of idiotype-anti-idiotype immune complexes after polyclonal activation induced by bacterial LPS. (1982) (29)
Analysis of spontaneous mRNA cytokine production in peripheral blood. (2002) (29)
IL-17 Production Elicited by Allo-Major Histocompatibility Complex Class II Recognition Depends on CD25posCD4pos T Cells (2008) (29)
Apoptosis: potential for disease therapies. (1998) (29)
Severe atherosclerosis of the aorta and development of peripheral T‐cell lymphoma in an adolescent with angiolymphoid hyperplasia with eosinophilia (2005) (29)
Reviving Function in CD4+ T Cells Adapted to Persistent Systemic Antigen1 (2009) (29)
Interleukin‐12 family members and type I interferons in Th17‐mediated inflammatory disorders (2009) (28)
Immunoregulatory mechanisms of T-cell-dependent shock induced by a bacterial superantigen in mice (1996) (28)
IL-6 produced by type I IFN DC controls IFN-gamma production by regulating the suppressive effect of CD4+ CD25+ regulatory T cells. (2005) (28)
The Replacement of Graft Endothelium by Recipient-Type Cells Conditions Allograft Rejection Mediated by Indirect Pathway CD4+ T Cells (2006) (28)
Early recurrence of hemolytic uremic syndrome in a renal transplant recipient during prophylactic OKT3 therapy. (1992) (28)
Rottlerin inhibits human T cell responses. (2007) (28)
Increased expression of Ia antigens on B cells after neonatal induction of lymphoid chimerism in mice: Role of interleukin 4 (1990) (28)
Regulation of Th2 Responses and Allergic Inflammation through Bystander Activation of CD8+ T Lymphocytes in Early Life (2010) (27)
Severe hemolysis due to a donor anti-D antibody after heart-lung transplantation. Association with lung and blood chimerism. (1993) (27)
Markers of HTLV-III in patients with end stage renal failure treated by haemodialysis. (1986) (27)
Defective translation of tumor necrosis factor mRNA in lipopolysaccharide-tolerant macrophages. (1996) (27)
Skin Graft Rejection Elicited by β2-Microglobulin as a Minor Transplantation Antigen Involves Multiple Effector Pathways: Role of Fas-Fas Ligand Interactions and Th2-Dependent Graft Eosinophil Infiltrates1 (2002) (27)
IL-4 and IL-13 mRNA real-time PCR quantification on whole blood to assess allergic response. (2005) (26)
Simultaneous induction of an idiotype, corresponding anti-idiotypic antibodies, and immune complexes during African trypanosomiasis in mice. (1982) (26)
Acute Liver Transplant Rejection Upon Immunosuppression Withdrawal in a Tolerance Induction Trial: Potential Role of IFN-γ-secreting CD8+ T Cells (2009) (26)
Interferon-alpha upregulates both interleukin-10 and interferon-gamma production by human CD4+ T cells. (1997) (26)
Preconditioning of donors with interleukin-10 reduces hepatic ischemia-reperfusion injury after liver transplantation in pigs (2003) (25)
IL‐5 in post‐traumatic eosinophilic pleural effusion (1993) (25)
Plasma endotoxin and tumor necrosis factor-α in the hyperkinetic state of cirrhosis (1995) (24)
Azodicarbonamide inhibits T-cell responses in vitro and in vivo (1999) (24)
Pregnancy and humoral immune response in mice chronically infected by Trypanosoma cruzi (1987) (24)
Interleukin-10 and its implications for immunopathology. (1995) (24)
Altered glomerular permeability in the early phase of immune complex nephritis. (1983) (24)
The protective role of interleukin-10 in endotoxin shock. (1994) (24)
N-Acetylcysteine derivative inhibits procoagulant activity of human islet cells (2007) (24)
Hyperactivity of donor B cells after neonatal induction of lymphoid chimerism in mice. (1988) (24)
Cuprophane haemodialysis induces upregulation of LPS receptor (CD14) on monocytes: role of complement activation. (1996) (23)
An Alternative Pathway of NF-κB Activation Results in Maturation and T Cell Priming Activity of Dendritic Cells Overexpressing a Mutated IκBα1 (2007) (23)
Possible nephrotoxicity of the prophylactic use of OKT3 monoclonal antibody after cadaveric renal transplantation. (1989) (22)
Defective CD3gamma gene transcription is associated with NFATc2 overexpression in the lymphocytic variant of hypereosinophilic syndrome. (2005) (22)
Patient perspectives regarding gene therapy in haemophilia: Interviews from the PAVING study (2020) (22)
Cutting Edge: Small Molecule CD40 Ligand Mimetics Promote Control of Parasitemia and Enhance T Cells Producing IFN-γ during Experimental Trypanosoma cruzi Infection1 (2007) (22)
Effects of systemic administration of rIL-10 in an in vivo model of alloreactivity. (1994) (21)
Foxp3+CD25+ T Regulatory Cells Stimulate IFN-γ-Independent CD152-Mediated Activation of Tryptophan Catabolism That Provides Dendritic Cells with Immune Regulatory Activity in Mice Unresponsive to Staphylococcal Enterotoxin B1 (2007) (21)
CD8+ T‐Cell Depletion and Rapamycin Synergize with Combined Coreceptor/Stimulation Blockade to Induce Robust Limb Allograft Tolerance in Mice (2008) (21)
Spontaneous and cycloheximide-induced interleukin-10 mRNA expression in human mononuclear cells. (1995) (21)
Distinct mechanisms are involved in tumoristatic and tumoricidal activities of monocyte-derived dendritic cells. (2004) (20)
The IgE humoral response in OKT3-treated patients. Incidence and fine specificity. (1996) (19)
Animal model of human disease. Proliferative glomerulonephritis associated with polyclonal B-cell activation. (1984) (19)
IL-10 inhibits the primary allogeneic T cell response to human peripheral blood dendritic cells. (1995) (19)
INFLUENCE OF DONOR‐RECIPIENT HLA‐DR MISMATCHES AND OKT3 PROPHYLAXIS ON CADAVER KIDNEY GRAFT SURVIVAL (1995) (19)
Boosting translational research on Alzheimer's disease in Europe: The Innovative Medicine Initiative AD research platform (2015) (19)
Pertussis toxin activates adult and neonatal naive human CD4+ T lymphocytes (2006) (18)
Public-private partnerships need honest brokering (2012) (18)
Interleukin-10 inhibits OKT3-induced cytokine release: in vitro comparison with pentoxifylline. (1993) (18)
Administration of anti‐CD3 monoclonal antibody during experimental Chagas’ disease induces CD8+ cell‐dependent lethal shock (1996) (18)
Evolution of renal function during treatment of kidney graft rejection with OKT3 monoclonal antibody. (1990) (18)
Dendritic cells overexpressing Fas‐ligand induce pulmonary vasculitis in mice (2004) (18)
Clonal Th2 cells associated with chronic hypereosinophilia: TARC-induced CCR4 down-regulation in vivo. (2001) (18)
Amplification of T-cell responses by neutrophils: relevance to allograft immunity. (2004) (18)
Infusion of donor-derived hematopoietic stem cells in organ transplantation: clinical data (2003) (18)
Prevention of OKT3 nephrotoxicity after kidney transplantation. (1996) (18)
Interleukin-5 production by T lymphocytes in atheroembolic disease with hypereosinophilia. (1995) (17)
Neutrophil‐dependent tumor rejection and priming of tumoricidal CD8+ T cell response induced by dendritic cells overexpressing CD95L (2008) (17)
Measuring the value of public–private partnerships in the pharmaceutical sciences (2012) (17)
Chronic rejection of major histocompatibility complex class II-disparate skin grafts after anti-CD3 therapy: a model of antibody-independent transplant vasculopathy. (1998) (17)
Interleukin-22 deficiency accelerates the rejection of full major histocompatibility complex-disparate heart allografts. (2008) (17)
Removal of beta 2-microglobulin by adsorption on dialysis membranes. (1987) (17)
Mature dendritic cells differentiated in the presence of interferon‐b and interleukin‐3 prime functional antigen‐specific CD8+ T cells (2005) (17)
The induction of human T cell unresponsiveness by soluble anti-CD3 mAb requires T cell activation. (1995) (17)
Transfection of Trypanosoma cruzi with Host CD40 Ligand Results in Improved Control of Parasite Infection (2005) (17)
Renal immunopathology in murine host-versus-graft disease. (1991) (17)
Anti-inflammatory effects of UV-irradiated lymphocytes: induction of IL-1Ra upon phagocytosis by monocyte/macrophages. (2005) (17)
Clonal Th 2 lymphocytes in patients with the idiopathic hypereosinophilic syndrome (2000) (17)
IL-17A Mediates Early Post-Transplant Lesions after Heterotopic Trachea Allotransplantation in Mice (2013) (16)
Isolation and infusion of donor CD34+ bone marrow cells in cadaver kidney transplantation. (1998) (16)
Cytokines in the pathophysiology of systemic lupus erythematosus. (1990) (16)
CD14‐independent responses induced by a synthetic lipid A mimetic (2010) (16)
CHIMERISM AND CYTOTOXIC T LYMPHOCYTE UNRESPONSIVENESS AFTER NEONATAL INJECTION OF SPLEEN CELLS IN MICE EFFECTS OF T CELL DEPLETION AND OF A SEMIALLOGENEIC OR FULLY ALLOGENEIC INOCULUM (1987) (15)
Tumor necrosis factor and intravenous gammaglobulins in common variable immunodeficiency. (1994) (15)
Renal allograft rupture: possible causes and results of surgical conservative management. (1981) (15)
100th Anniversary of Jules Bordet's Nobel Prize: Tribute to a Founding Father of Immunology (2019) (15)
Monocyte procoagulant activity induced by in vivo administration of the OKT3 monoclonal antibody. (1996) (15)
Cytokines involved in the downregulation of allergic airway inflammation. (1997) (15)
Adhesion molecules in antibacterial defenses: effects of bacterial extracts. (1992) (15)
An alternative pathway of NF-kappaB activation results in maturation and T cell priming activity of dendritic cells overexpressing a mutated IkappaBalpha. (2007) (14)
Interleukin-10 and liver diseases. (1999) (14)
Expansion of regulatory CD8+CD25+ T cells after neonatal alloimmunization (2011) (14)
Acute haemodialysis membrane-associated reactions. (1996) (14)
Infections in Chronic Hemodialysis Patients (1991) (14)
POST-TRANSPLANTATION LYMPHOPROLIFERATIVE DISORDER AND OKT3. REPLY (1991) (14)
Efficacy of oral immunotherapy on respiratory infections in hemodialysis patients: a double-blind, placebo-controlled study. (1999) (14)
Interleukin-10 inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin-1 beta production in the brain without affecting the activation of the hypothalamus-pituitary-adrenal axis. (1995) (13)
OM-85 BV upregulates the expression of adhesion molecules on phagocytes through a CD 14-independent pathway. (1996) (13)
Dose-effect of interleukin-10 and its immunoregulatory role in Crohn's disease. (2002) (13)
A rapid test to monitor alloreactive responses in whole blood using real-time polymerase chain reaction. (2005) (13)
Bacterial extract OM85-BV induces interleukin-12-dependent IFN-gamma production by human CD4+ T cells. (1998) (13)
CD3 antibody-induced IL-10 in renal allograft recipients: an in vivo and in vitro analysis. (1999) (13)
In vitro correlates of the acute toxic syndrome induced by some monoclonal antibodies: a rationale for the design of predictive tests. (1995) (13)
Acute toxicity of anti-CD3 monoclonal antibody in mice: a model for OKT3 first dose reactions. (1990) (13)
CD8+ T Lymphocytes Regulating Th2 Pathology Escape Neonatal Tolerization1 (2003) (13)
Benefit Corporation: a path to affordable gene therapies? (2019) (13)
Interleukin-10 as an anti-stress cytokine. (1997) (13)
Improving R&D productivity of pharmaceutical companies through public–private partnership: experiences from the Innovative Medicines Initiative (2012) (13)
Lung rejection occurs in lung transplant recipients with blood chimerism. (1997) (13)
Medicines Adaptive Pathways to Patients (MAPPs) (2016) (13)
Interleukin-9 stimulates the production of interleukin-5 in CD4+ T cells. (2005) (12)
Online Information on Probiotics: Does It Match Scientific Evidence? (2020) (12)
Failure of two subsequent renal grafts by anti-GBM glomerulonephritis in Alport's syndrome: case report and review of the literature (1990) (12)
Beneficial effects of prophylactic OKT3 in cadaver kidney transplantation: comparison with cyclosporin A in a single-center prospective randomized study. (1991) (12)
Methotrexate inhibits LPS-induced tumor necrosis factor production in vivo. (1999) (12)
Procoagulant properties of OKT3 at the monocyte level: inhibition by pentoxifylline. (1993) (12)
Persistence of anti-donor helper T cells secreting interleukin 4 after neonatal induction of transplantation tolerance. (1989) (12)
Th17 Alloimmunity Prevents Neonatal Establishment of Lymphoid Chimerism in IL‐4‐Deprived Mice (2012) (12)
The TH1/TH2 concept and its relevance to renal disorders and transplantation immunity. (1995) (12)
Histamine and basophils in delayed-type hypersensitivity reactions. (1973) (11)
OKT3 for induction of immunosuppression in renal transplantation (1993) (11)
OM197-MP-AC induces the maturation of human dendritic cells and promotes a primary T cell response. (2003) (11)
Immunostimulatory properties of human dendritic cells generated using IFN-β associated either with IL-3 or GM-CSF (2005) (11)
Multiple blood transfusions and iron overload in patients receiving haemodialysis. (1987) (11)
35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts. (1999) (11)
Down-regulation of interleukin-2 and interferon-gamma and maintenance of interleukin-4 and interleukin-10 production after administration of an anti-CD3 monoclonal antibody in mice. (1999) (11)
A conventional protein kinase C inhibitor targeting IRF-3-dependent genes differentially regulates IL-12 family members. (2011) (11)
Trapidil inhibits monocyte CD40 expression by preventing IFN-gamma-induced STAT1 S727 phosphorylation. (2004) (11)
Effects of serotonin on coronary arteries of cardiac transplant recipients. (1993) (11)
OKT3 serum levels as a guide for prophylactic therapy: a pilot study in kidney transplant recipients (1994) (11)
Induction of interleukin-6 and interleukin-10 by the okt3 monoclonal-antibody : possible relevance to posttransplant lymphoproliferative disorders (1992) (11)
Immunological Safety of Vaccines: Facts, Hypotheses and Allegations (2003) (10)
Failure of two subsequent renal grafts by anti‐GBM glomerulonephritis in Alport's syndrome: case report and review of the literature (1990) (10)
Increased IL-4 production and decreased CD40L expression by newborn T cells contribute to transplantation tolerance. (1999) (10)
Early renal graft failure due to recurrence of Wegener's granulomatosis under cyclosporine therapy (1989) (10)
Viva Europa, a Land of Excellence in Research and Innovation for Health and Wellbeing (2017) (10)
The idiopathic hypereosinophilic syndrome: clinical presentation, pathogenesis and therapeutic strategies. (1998) (10)
Donor T-cell development in host thymus after heterotopic limb transplantation in mice. (2007) (10)
Preemptive Antibody Therapy for Vaccine Breakthrough SARS-CoV-2 Infection in Immunocompromised Patients (2021) (10)
Benchmarking the scientific output of the Innovative Medicines Initiative (2015) (10)
Downregulation of antigen-presenting cell functions after administration of mitogenic anti-CD3 monoclonal antibodies in mice. (1999) (10)
Differential effects of interleukin-10 on the production of interleukin-12 and interleukin-8 by human dendritic cells generated from peripheral blood. (1996) (10)
Translating transplantation tolerance in the clinic: where are we, where do we go? (2009) (10)
Plasma endotoxin and tumor necrosis factor-alpha in the hyperkinetic state of cirrhosis. (1995) (10)
From autoimmune responses to autoimmune disease: what is needed? (2001) (9)
Cytokines in alcoholic liver cirrhosis. (1994) (9)
Online Information of Vaccines: Information Quality, Not Only Privacy, Is an Ethical Responsibility of Search Engines (2020) (9)
New Frontiers for Collaborative Research (2013) (9)
Prophylactic OKT3: practical considerations for the prevention of first-dose reactions. (1993) (9)
Effects of chronic renal failure and hemodialysis on hormonal evaluation of pregnancy. (1988) (9)
Urinary endopeptidase 24.11 as a new marker of proximal tubular injury. Preliminary study in kidney transplant recipients. (1993) (9)
OKT3 prophylaxis improves long-term renal graft survival in high-risk patients as compared to cyclosporine: combined results from the prospective, randomized Belgian and US studies. (1995) (9)
Editorial: The Innovative Medicines Initiative – collaborations are key to innovating R&D processes (2014) (9)
Single cell analysis of antigen-specific T cell responses in HIV-infected individuals. (1999) (9)
Patients' motives for consenting or refusing to participate in a clinical trial in organ transplantation (2013) (8)
Transplantation Research: Will We Ever Reach the Holy Grail? (2009) (8)
Boosting vaccine power. (2009) (8)
Continuous ambulatory peritoneal dialysis, protective against developing dialysis-associated amyloid? (1989) (8)
Eosinophils Express a Functional Receptor for Interferon a : Inhibitory Role of Interferon a on the Release of Mediators (2002) (8)
European research on cell and organ transplantation: towards novel opportunities? (2007) (8)
In vivo immunosuppression induced by a weakly mitogenic antibody to mouse CD3: evidence that induction of long-lasting in vivo unresponsiveness requires TcR signaling. (1994) (8)
Interleukin-10 as a protective cytokine produced during sepsis (1996) (8)
Hypereosinophilic syndrome induced by neonatal immunization against MHC class II alloantigen: critical role of IL‐4 (2002) (8)
A rapid test of alloreactivity based on interleukin-2 mRNA expression might identify liver transplant recipients with donor-specific hyporesponsiveness. (2007) (8)
Erratum to “Cytokine mRNA quantification by real-time PCR” [J. Immunol. Methods 259 (2002) 55–64] (2002) (8)
Phase I Safety and Immunogenicity of A Three‐Component H. Pylori Vaccine (2003) (8)
Vaccines: Accelerating Innovation and Access. (2017) (7)
Antibody-based therapies for COVID-19: Can Europe move faster? (2020) (7)
Induction of tolerance in solid organ transplantation: the rationale to develop clinical protocols in liver transplantation. (2009) (7)
Patient preferences for gene therapy in haemophilia: Results from the PAVING threshold technique survey (2021) (7)
Role of the TH1-TH2 balance in the development of autoimmunity in rats. (1993) (7)
Early neutralization of IL-4 but not of IL-10 abrogates neonatal induction of transplantation tolerance in mice. (1995) (7)
Endotoxin hyperresponsiveness upon CD4+ T cell reconstitution in lymphopenic mice: control by natural regulatory T cells (2008) (7)
Public-Private Partnership: A New Engine for Translational Research in Neurosciences (2014) (7)
Emergence of Th2-like cells after anti-CD3 monoclonal antibody administration in mice. (1995) (6)
Lipopolysaccharide induces upregulation of neutral endopeptidase 24.11 on human neutrophils: involvement of the CD14 receptor. (1995) (6)
Immediate hypersensitivity reactions and hemodialysis. (1993) (6)
Autoimmune disease after neonatal injection of semi-allogeneic spleen cells in mice: involvement of donor B and T cells and characterization of glomerular deposits. (1987) (6)
More on AIDS in patients on dialysis. (1986) (6)
Persistent T cell and B cell activities in the duodenal mucosa of AIDS patients (1998) (6)
Pathological expression of idiotypic interactions: Immune complexes and cryoglobulins (2005) (6)
Apoptosis: a target for potentiation of UV-induced IL-1Ra synthesis by IVIg. (2007) (6)
Editorial: With Obesity Becoming the New Normal, What Should We Do? (2019) (6)
Regulatory Role of Host CD8+ T Lymphocytes in Experimental Graft-versus-Host Disease across a Single Major Histocompatibility Complex Class II Incompatibility (2005) (6)
Membrane-related eosinophilia in hemodialysis. (1988) (6)
The Rational Use of Animals in Drug Development: Contribution of the Innovative Medicines Initiative (2012) (5)
The Innovative Medicines Initiative moves translational immunology forward (2013) (5)
The specificity of tolerance induction in delayed hypersensitivity. (1970) (5)
Patient Preferences to Assess Value IN Gene Therapies: Protocol Development for the PAVING Study in Hemophilia (2021) (5)
Azodicarbonamide as a new T cell immunosuppressant: synergy with cyclosporin A. (2001) (5)
N-Acetylcysteine Derivative Inhibits CD40-Dependent Proinflammatory Properties of Human Pancreatic Duct Cells (2008) (5)
Ultrastructural demonstration of retrovirus antigens with immuno-gold staining in prodromal acquired immune deficiency syndrome. (1984) (5)
Autoimmunity and glomerulonephritis after neonatal induction of lymphoid chimerism in mice: role of donor B cells and host T cells. (1988) (5)
Complement activation and leucopenia on cellulosic haemodialyzers: influence of the membrane area and role of hydroxyl moieties. (1987) (5)
Disorders of Iron Metabolism in the Uremic Patient (1989) (5)
The impact of maternal infection or immunization on early-onset autoimmune diabetes. (2003) (5)
Molecular mechanisms of extracellular adenine nucleotides-mediated inhibition of human Cd4+ T lymphocytes activation (2005) (5)
Endogenous interleukin-10 protects against death in septic peritonitis in mice (1994) (5)
Increased IL-6 production and IL-6-mediated Ig secretion in murine host-vs-graft disease. (1993) (5)
Sublingual immunotherapy: the quest for innovative adjuvants (2008) (4)
COVID-19 and beyond: a call for action and audacious solidarity to all the citizens and nations, it is humanity’s fight (2020) (4)
Induction of T-cell anergy by OKT3 requires cyclosporine-insensitive activation signals. (1995) (4)
The Protective Role of Interleukin-10 in Sepsis (1994) (4)
Efficacy of rejection prophylaxis with OKT3. (1996) (4)
The inflammatory cascade of liver ischemia and reperfusion: from the donor to the recipient (1998) (4)
Beneficial effects of some donor-recipient HLA-DR mismatches on cadaveric graft survival: proposal for a new selection policy of recipients. (1991) (4)
How to predict adverse immune reactions induced by pharmaceutical compounds. (1995) (4)
Interleukin-10 as a key regulator of inflammation and stress responses (2000) (4)
Impaired antigen-presenting cell function contributes to T-cell hyporesponsiveness in stable lung transplant recipients. (2000) (4)
The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4(+) T cells. (2006) (4)
Relation of coronary hypersensitivity to serotonin in cardiac transplant recipients to vessel wall morphology and effect of vitamin C. (2006) (4)
GenisteinTLR4-Stimulated Dendritic Cells Exposed to B-Dependent Gene Expression in k A Critical Role for p53 in the Control of NF-BergheMarine, (2007) (4)
New concepts on the pathogenesis of autoimmune disease. (2001) (4)
Skin biopsies in DC vaccines for stage III–IV melanoma patients: Role of neutrophils? (2007) (3)
[What is the fair price of innovative therapy?] (2020) (3)
In vivo induction of IL-10 by anti-CD3 monoclonal antibody in mice. (1993) (3)
CD8+ T-cell subpopulations in human abdominal aortic aneurysm lesion. (2005) (3)
T cell subsets in glomerular diseases (2004) (3)
Eosinophilia in Chronic Dialysis (1990) (3)
Immune complexes, polyclonal B cell activation and idiotypic interactions in protozoan diseases (1982) (3)
IFN-gamma, IL-4, IL-10 and IL-12 gene expression in BCG-Leishmania vaccination of Trypanosoma cruzi-infected mice. (2000) (3)
Idiotypic interactions and immunopathology. (1982) (3)
A possible role for idiotypic interactions in the pathogenesis of immune complex glomerulonephritis. (1982) (3)
Free Drug Samples and the Opioid Crisis. (2018) (3)
Tolerance in liver transplantation: facts and perspectives. (1997) (3)
Online information of vaccines: information quality is an ethical responsibility of search engines (2019) (3)
Clonal expansion of helper type 2 lymphocytes as a cause of the hypereosiophilic syndrome: clinical and immunological aspects (2001) (3)
Hypereosinophilic syndrome. (2003) (3)
Unexpected effects of viral interleukin-10-secreting dendritic cells in vivo: preferential inhibition of TH2 responses. (2004) (3)
Parathyroid adenoma causing persistent hypercalcaemia after rhabdomyolysis-induced acute renal failure. (1986) (3)
Effects of interleukin-10 on the immunoactivating and immunosuppressive properties of anti-CD3 monoclonal antibody. (1994) (3)
Fate of beta-2-microglobulin during dialysis on polysulfone and AN69 membranes. (1989) (3)
[The role of neutrophils during allograft rejection]. (2005) (3)
Reflections on the Innovative Medicines Initiative (2011) (3)
Comparison between prophylactic use of OKT3 and cyclosporine in cadaveric renal transplantation. (1990) (3)
Interleukin-10 Production during Septic Shock (1996) (3)
Biomarkers of tolerance in kidney transplants (2007) (2)
Bernard associated with chronic hypereosinophilia prevents spontaneous apoptosis of clonal Th 2 cells α (2000) (2)
The use of OKT3 in clinical transplantation (1995) (2)
Effect of iron overload on superoxide anion production by granulocytes in haemodialysis patients (1985) (2)
Usefulness of 99mTc pyrophosphate bone scintigraphy in the survey of dialysis osteodystrophy. (1985) (2)
INDICES OF TOLERANCE: INTERIM REPORT. (2006) (2)
Defective production of IFN-γ in neonatally tolerant mice: Involvement of IL-10 (1994) (2)
[Glomerulopathies associated with parasitoses]. (1985) (2)
Blood urea nitrogen, middle molecules and uremic morbidity in hemodialyzed patients (1986) (2)
Pentoxifylline prevents TNF production and activation of coagulation induced by OKT3 in vitro but not in vivo (1993) (2)
are selectively blunted in cord blood cells Interferon regulatory factor 3-dependent responses to lipopolysaccharide (2013) (2)
[Nephrotoxicity of anti-CD3 monoclonal antibodies]. (1991) (2)
High or low dose steroid therapy for acute renal transplant rejection after prophylactic OKT3 treatment: a prospective randomized study. (1992) (2)
Interhukin 10 Reduces the Release of Tumor Necrosis Factor and Prevents Lethality in Experimental Endotoxemia By Catherine G6rard, .1 Catherine Bruyns,* Arnaud Marchant,S (1993) (2)
[Allogenic reaction, a model of autoimmunity]. (1994) (2)
Cellular and molecular aspects of systemic autoimmunity (1993) (2)
Role of CD18‐dependent and CD18‐independent mechanisms in the increased leukocyte adhesiveness and in the variations of circulating white blood cell populations induced by anti‐CD3 monoclonal antibodies (1996) (2)
Detection of blood chimerism after lung transplantation: superiority of nested as compared to standard polymerase chain reaction amplification. (1995) (2)
Dissociation between chimerism and skin graft tolerance after neonatal injection of allogenic spleen cells. (1998) (2)
IL-6 Produced by Type I IFN DC Controls IFN-γ Production during the MLR by Blocking the Suppressive Effect of Regulatory T Cells. (2004) (2)
Contributions of innate immunity to allograft rejection and survival (2003) (2)
[Nephrotic syndrome and non-steroid anti-inflammatory agents]. (1982) (2)
[Anti-tumor immunotherapy based on dendritic cells]. (2001) (2)
The Cholinergic Anti-Inflammatory Pathway Delays TLR-Induced Skin Allograft Rejection in Mice: Cholinergic Pathway Modulates Alloreactivity (2013) (2)
Reflections on the Collaborative Fight Against COVID-19 (2020) (2)
Faculty Opinions recommendation of Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. (2008) (2)
The Safety of Anti-SARS-CoV-2 Vaccines: Vigilance Is Still Required (2022) (2)
Susceptibility and resistance to autoimmunity following neonatal injection of semi-allogeneic spleen cells in rats. (1992) (2)
Interleukin-10 and Other Suppressive Cytokines (1998) (2)
Jules Bordet, un homme de conviction (2020) (2)
Prescription opioids and economic hardship in France (2020) (2)
Education in Medicine: Moving the Boundaries to Foster Interdisciplinarity (2016) (2)
Clarifying knowledge ownership in Europe's medicines initiative (2010) (2)
F.96. T Cell Repertoire Analysis of Stable Kidney Graft Recipients for Detection of Low and High Risk of Chronic Rejection (2008) (1)
Donor pretreatment with IL-10 decreases TNF, IFN-gamma release and liver injury after cold ischemia-reperfusion in mice (1998) (1)
Interleukin-10 in lung inflammation and bronchial asthma (2000) (1)
Interleukin-10 (IL-10) decreases severity of acute necrotizing pancreatitis in mice (1995) (1)
[Reversible nephrotic syndrome and acute renal failure associated with alclofenac administration]. (1982) (1)
Book Review Renal Transplantation By Ron Shapiro, Richard L. Simmons, and Thomas E. Starzl. Stamford, Conn., Appleton & Lange, 1997. 572 pp., illustrated. $100. 0-8385-8383-0 (1998) (1)
Philanthropies as partners for drug development in public–private partnerships (2015) (1)
Data Standards are needed to move Translational Medicine forward (2013) (1)
Immunotherapy using dendritic cells (2000) (1)
Interleukin 2 release assay in limiting dilution microcultures: Possible application to fine needle aspirates of kidney transplants (1985) (1)
A randomized phase I/II trial of antitumor vaccination using the recombinant MAGE-A3 protein loaded on myeloid DC or mixed with adjuvant ASO2B in melanoma patients (2005) (1)
Detrimental role of donor-recipient HLA-DQ5 and -DQ6 disparities on cadaver kidney graft survival. (1992) (1)
Sensitization to carrier antigens following delayed reactions to the hapten. (1970) (1)
Trypanosoma cruzi Experimental during γ and Enhance T Cells Producing IFN-Mimetics Promote Control of Parasitemia Cutting Edge : Small Molecule CD 40 Ligand (2007) (1)
Boosting POWER Vaccine (2009) (1)
103 Interleukin-27 Synthesis Induced by Toll-like Receptor Ligation Critically Depends on Interferon Regulatory Factor 3 (2007) (1)
Building new models of drug discovery in Europe: The Innovative Medicines Initiative (2014) (1)
Apoptosis, tolerance and immunoregulation - Integrated pathways for immune system homeostasis (1998) (1)
Immune complex diseases resulting from idiotypic or allogenic interactions (1984) (1)
The innovative medicines initiative: a case study for new ways of working in drug R&D. (2014) (1)
Kidney transplantation in Alport's syndrome and related diseases. (1990) (1)
High or low dose steroid therapy for acute renal transplant rejection after prophylactic OKT3 treatment: a prospective randomized study (1992) (1)
Vaccines, Shots That Protect You (2019) (1)
Failure to remove polyspecific anti HLA antibodies with plasma exchanges and immunosuppression (1985) (1)
[Chronic hypereosinophilia: a model of Th2 disorders]. (2000) (1)
Vaccination and Autoimmune Diseases (2016) (1)
T-cell-depleted stem-cell transplantation for rheumatoid arthritis (1998) (1)
[Jules Bordet, a man of conviction. Centenary of his Nobel Prize]. (2020) (1)
[Glomerulonephritis by glomerular anti-basement membrane antibodies after renal transplantation]. (1989) (1)
AZODICARBONAMIDE AS A NEW IMMUNOSUPPRESSIVE AGENT (1999) (1)
Oxidised LDL induce procoagulant activity (PCA) in human monocytes (1994) (1)
Modulation of murine host‐versus‐graft disease by anti‐CD3 monoclonal antibody (1991) (1)
Interleukin-10 as a protective cytokine produced during human septicemia and septic shock (1996) (1)
oligodeoxynucleotides are impaired in human newborns Blood plasmacytoid dendritic cell responses to CpG (2013) (1)
Increase of Ia expression on B cells during the course of mercury-induced autoimmune disease in Brown Norway rats (1990) (1)
[Immunotherapy based on dendritic cells: from experimentation to clinical development]. (2003) (1)
Impairment in the capability to release interleukin-1 and interleukin-2 in the early phase of hemodialysis (1986) (1)
Corrigendum: Fake News or Weak Science? Visibility and Characterization of Antivaccine Webpages Returned by Google in Different Languages and Countries (2019) (1)
Hypoxemia, Leukopenia and Complement Activation with Large Surface Hemodialyzers — Comparison of Cellulose Acetate with Cuprophan® (1986) (1)
Faculty Opinions recommendation of Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function. (2005) (0)
Acute Allograft Rejection: Immunobiology and Therapeutic Strategies (1992) (0)
T Lymphocytes + Activation of Human CD 4 Extracellular Adenine Nucleotides Inhibit the Boeynaems and Didier Communi (2002) (0)
In vitro immunomodulation of RH IL-10 on TNF-α secretion by lamina propria mononuclear cells in Crohn's disease (1998) (0)
IRF3 is required for induction of allergic airway inflammation by dendritic cells (2009) (0)
Activation markers, LTC4 release and quantitative real time PCR for the TH2 cytokines (2003) (0)
Is uremic morbidity more related to BUN than to middle molecule clearance (1984) (0)
A model of proliferative glomerulonephritis (1984) (0)
EARLY IMMUNOSUPPRESSION WITHDRAWAL AFTER CADAVER LIVER TRANSPLANTATION USING ATG AND RAPAMYCIN IN THE IMMEDIATE POSTTRANSPLANT PERIOD (2008) (0)
Urinary endopeptidase 24.11 as a marker of renal tubular injury (1991) (0)
[Is immune complex glomerulonephritis due to idiotypic interactions between immunoglobulin molecules?]. (1982) (0)
Homeostatic proliferation of memory-type CD8(+) T cells as a cause of acute rejection upon immunosuppression withdrawal in liver transplant recipients (2009) (0)
of extracellular ATP in human dendritic cells Thrombospondin-1 and indoleamine 2,3-dioxygenase are major targets (2013) (0)
Antiinflammatory effects of Mycophenolate mofetil (MMF): Inhibition of TNF and upregulation of IL-10 synthesis after LPS challenge in vivo (1998) (0)
Rejection Th 17-Mediated Minor Antigen-Disparate Critical Role of Regulatory T Cells in (2010) (0)
Type I interferons differentially regulate the synthesis of TH2-type cytokines by human CD4+ T cells (1997) (0)
Protein kinase C: a key regulator of dendritic cell function (2007) (0)
[Parathyroid adenoma detected by a cold nodule on thyroid scintigraphy with technetium]. (1981) (0)
Chromosome abnormalities in hypereosinophilic syndrome associated with TH-2 cell clonality. (1999) (0)
Role of dendritic cells in graft rejection and graft-versus-Host disease (2008) (0)
Vaccination and autoimmunity (2004) (0)
CD11b and CD45 on monocytes (MMC) during hemodialysis (HD) (1991) (0)
Toll like receptor responses in neonatal dendritic cells (2008) (0)
Monitoring peripheral blood regulatory T cells on clinically defined groups of kidney transplant recipients (2007) (0)
Islet xenograft rejection in absence of CD8+ T cells does not require either interferon-gamma or interleukin-5. (2002) (0)
43 Differential Regulation of Interleukin-12 Family Members in Response to Toll-Like Receptor Ligation: Critical Role of Interferon Regulatory Factor 3 (2007) (0)
Early role of IL-17 and calcineurin inhibitor-mediated Th2- and Th17-polarization of chronic trachea allograft rejection pathways (2014) (0)
IN VITRO ANTIGEN PRESENTING CELL FUNCTION IS DEFICIENT IN STABLE LUNG TRANSPLANT RECIPIENTS. (1999) (0)
Two-Step Activation Process IL-27p28 Gene Expression Revealing a Factor 3 Complex in TLR-Mediated Critical Role of the IFN-Stimulated Gene (2010) (0)
Hematopoietic stem cells as inducers of tolerance to solid organ transplants (2004) (0)
Decreased interleukin-4 secretion by intestinal and circulating lymphocytes in adult onset coeliac disease (1997) (0)
Production and use of dendritic cells (2001) (0)
1 can function as targets for leukemia-reactive CTL presented epitopes of the Wilms tumor antigen - Two distinct HLA-A0201 (2013) (0)
Mechanisms of action and clinical uses of type-I interferons (2000) (0)
Immunomodulators: interleukins, interferons, and the OKT3 monoclonal antibody (2003) (0)
TLR4-Stimulated Dendritic Cells Exposed to B-Dependent Gene Expression in κ A Critical Role for p53 in the Control of NF- (2013) (0)
Faculty Opinions recommendation of Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. (2007) (0)
Dampening of alloimmunity by Toll-Like receptor for desensitization (2007) (0)
Faculty Opinions recommendation of Messenger RNA for FOXP3 in the urine of renal-allograft recipients. (2005) (0)
Molecular proﬁling of CD3 (cid:1) CD4 (cid:2) T cells from patients with the lymphocytic variant of hypereosinophilic syndrome reveals targeting of growth control pathways (2009) (0)
[Role of interleukin-10 in the regulation of immune responses in infectious diseases]. (1994) (0)
Adjuvant activity on human cells in vitro. (2010) (0)
A rapid test of alloreactivity based on IL2 mRNA expression might identify liver transplant recipients developing donor-specific hyporesponsiveness (2007) (0)
IRF3 is required for the induction of allergic airway inflammation by lung dendritic cells in a mouse model of house dust mite-induced atopic asthma (2009) (0)
Early mediators and downstream effectors of dsRNA-induced beta cell apoptosis: the role of IRF-3 and ER stress (2007) (0)
Recognition of Allograft by T Cells Acute Rejection in the Absence of Cognate (2001) (0)
Imbalance in the production of interferon-gamma and interleukin-4 in a patient with Ommen's syndrome: rationale for interferon-gamma therapy (1992) (0)
Vaccines and Antibodies: Weapons in the Fight Against Ebola Virus (2021) (0)
IRF3 is essential for house dust mite-induced airway allergy in mice (2011) (0)
Th17 (PP-014) (2010) (0)
Tolerance Suppressor Cells in Superantigen-Induced Respectively as Inducer and Effector T T Cells Act − CD 25 + and CD 4 + CD 25 + CD 4 (2003) (0)
Hypereosinophilic syndromes: a novel therapeutic indication for tyrosine kinase inhibitors and IL-5 antagonists (2006) (0)
Analysing skin-infiltrating T lymphocytes from a patient with a chronic inflammatory GVHD-like disease (2008) (0)
Idiopathic hypereosinophilic syndrome (2004) (0)
Role of cytokines in the induction of autoimmunity (1990) (0)
Erratum (1991) (0)
Th 2-Dependent Graft Eosinophil Infiltrates Role of Fas-Fas Ligand Interactions and Pathways : Antigen Involves Multiple Effector-Microglobulin as a Minor Transplantation 2 β Skin Graft Rejection Elicited (2002) (0)
Ultrastructural demonstration ofretrovirus antigens withimmuno-gold staining inprodromal acquired immunedeficiency syndrome (1984) (0)
[Comparative effects of oral water load of different mineral compositions on the excretion of ions and oxalic acid]. (1984) (0)
Study of the development of Th17-type immune response in early life (2012) (0)
Abstracts of the meeting of the Belgian Society of Nephrology (11 June 1994) (1995) (0)
Migratory and specific antitumoral immunostimulatory capacities of new dendritic cells generated with IL-3 and IFNβ in melanoma patients (2005) (0)
Implication of vascular endothelium and interleukin-22 in rejection of cardiac allografts (2010) (0)
[Allogenic interactions in immunopathology]. (1985) (0)
Gamma-delta T cells (WS-094) Chairpersons: Yoshimasa Tanaka, Marc Bonneville (2010) (0)
[Autoimmune syndrome associated with host versus graft reaction in the mouse]. (1989) (0)
properties monocytes into dendritic cells with potent helper T-cell stimulatory cooperate to induce differentiation of β Interleukin-3 and interferon (2013) (0)
Method of inhibiting cell cytokine production. (1997) (0)
[Involvement of natural regulatory lymphocytes in allograft tolerance]. (2009) (0)
Clinical-Grade Type I IFN-DC Differentiated in the Presence of Either IL-3 or GM-CSF Show Similar Phenotypic and Functional Proprieties. (2004) (0)
The antigenic components of naturally occuring immune complexes (1983) (0)
Regulatory role and pharmacological modulation of interleukin 10 production during septic shock (1996) (0)
allospecific T-cell responses in vivo Dendritic cells overexpressing CD95 (Fas) ligand elicit vigorous (2013) (0)
A Global Perspective on Vaccines: Priorities, Challenges and Online Information (2020) (0)
Unexpected effects of viral interleukin-10-transduced allogenic dendritic cells in vivo: preferential inhibition of Th2 responses (2004) (0)
Cyclosporine a Drives a Th17 and Th2 Mediated Post-Transplant Obliterative Airway Disease: 1729 (2012) (0)
COVID-19 and beyond: a call for action and audacious solidarity to all the citizens and nations, it is humanity’s fight [version 1; peer review: awaiting peer review] (2020) (0)
Epidemiology of hepatitis B virus and non A - non B virus hepatitis in a dialysis unit (1986) (0)
Inability of OKT3 to prevent donor-derived ABO hemolytic anemia in a kidney-pancreas transplant recipient (1995) (0)
Regulatory mechanisms in toll-like receptir pathways: control of dendritic cell functions by protein kinases (2005) (0)
Blood urea nitrogen and morbidity in dialysed patients (1983) (0)
Chapter 18 – Allogeneic Diseases (1994) (0)
COVID-19 and beyond: a call for action and audacious solidarity to all the citizens and nations, it is humanity’s fight [version 1; peer review: 3 approved with reservations] (2021) (0)
Des vaccins plus efficaces (2009) (0)
Allergy diagnosis: Value of CD63 and CD203c basophil activation markers, LTC4 release and quantitative real time PCR for Th2 cytokines (2003) (0)
Potentially lifesaving vaccines in need of new adjuvants (2009) (0)
Autoimmune disorders: toward more efficient and safer therapies (2009) (0)
Benefit Corporation: a path to affordable gene therapies? (2019) (0)
Su.97. Characterization of Cd4 T Lymphocyte Response to Anti-Hepatitis B Vaccination (2006) (0)
Inflammatory and helper T lymphocyte responses in human abdominal aortic aneurysm (2006) (0)
OKT3 Nephrotoxicity: From acute tubular necrosis to hemolytic uremic syndrome (1998) (0)
[Therapeutic innovation for the common good]. (2022) (0)
Dendritic cells generated in presence of interferon-β promote TH2 responses (1998) (0)
COVID-19 and Beyond: A Call for Action and Audacious Solidarity to All the Citizens and Nations, It Is Humanity’s Fight (2020) (0)
A role for TH2 cells in chronic allograft rejection (1997) (0)
ACUTE SKIN GRAFT REJECTION INDUCED BY β2 MICROGLOBULIN- ASSOCIATED MINOR TRANSPLANTATION ANTIGENS: CHARACTERISATION IN β2 MICROGLOBULIN-DEFICIENT MICE. (1999) (0)
Lymphadenopathy following COVID-19 vaccination: a wake-up call from case reports. (2023) (0)
Implications de l'interleukine 10 en immunopathologie : De la fonction aux maladies glomérulaires (1994) (0)
New project uses real-life patient data for drug development (2014) (0)
Identification of tolerant patients based on a combinational analysis of foxp3 and aMannosidase transcription (2007) (0)
Editorial: Research reproducibility and preventing fraud (2022) (0)
growth control pathways lymphocytic variant of hypereosinophilic syndrome reveals targeting of T cells from patients with the + CD4 - Molecular profiling of CD3 (2011) (0)
CROSS-PLATFORM BIOMARKER SIGNATURE TO IDENTIFY RENAL TRANSPLANT TOLERANCE IN HUMANS.: 3352 (2010) (0)
Predominant production of gamma interferon after a tetanus vaccine booster in healthy controls and HIV-infected patients (1997) (0)
Interleukin-22 plays a protective role against ischemia-reperfusion injury in mice hearts: 4AP6-8 (2008) (0)
Venom immunotherapy (VIT) results in a modified Th2 response (2003) (0)
Defective production of IFN-gamma in neonatally tolerant mice: involvement of IL-10. (1994) (0)
FasL deficiency does not prevent acute rejection but decreases eosinophilic infiltration after concordant islet xenotransplantation in mice (1999) (0)
Detrimental role of donor‐recipient HLA‐DQ5 and ‐DQ6 disparities on cadaver kidney graft survival (1992) (0)
Role of CD18-dependent and CD18-independent mechanisms in the increased leukocyte adhesiveness and in the variations of circulating white blood cell populations induced by anti-CD3 monoclonal antibodies (1996) (0)
Sulfadiazine-induced obstructive renal failure in a kidney transplant recipient (1992) (0)
3Critically Depends on IFN Regulatory Factor IL-27 Synthesis Induced by TLR Ligation (2007) (0)
Venom immunotherapy results in a modified TH 2 response (2003) (0)
Experimental and clinical studies on the imunosuppressive and toxic effects of anti-CD3 monoclonal antibodies (2000) (0)
Helper T cell dysfunctions in a patient with Omenn's syndrome: modulation by IFN-gamma therapy. (1993) (0)
Mucosal lymphocytes from AIDS patients severely depressed systemic immunity still secrete large amounts of IFN-γ and IL-4 in the intestinal mucosa (1997) (0)
Differential antibody responses to Pneumococcal and Tetanus vaccines in asymptomatic HIV-infected patients : a serological and cellular study (1994) (0)
Su.47. The Proinflammatory Action of Cd4+Cd25− T-Cells in Murine Endotoxemia Is Controlled By Naturally Occurring Cd4+Cd25+ Regulatory T-Cells (2006) (0)
Protein Kinase C α Is Critically Involved in MyD88-Dependent Toll-Like Receptor 2-Mediated Activation of Dendritic Cells. (2007) (0)
DAMPENING OF ALLOIMMUNITY BY TOLL-LIKE RECEPTOR 4 DESENSITIZATION: 854 (2008) (0)
and Proliferate In Vivo in Humans Lymphocytes Produce Multiple Cytokines T + Antigen-Specific Central Memory CD4 (2014) (0)
Incorporation of oleate (OL), arachidonate (AA) and eicosapentaenate (EPA) into peripheral blood mononuclear cells (PBMC) modulates pro-coagulant activity (PCA) (1994) (0)
Critical role of NKT cell-derived IL-5 and eosinophils in liver injury induced by concanavalin a in mice (2001) (0)
[Favourable effects of some HLA-DR disparities on kidney graft survival. Proposal for a new recipient selection policy]. (1991) (0)
Human monocyte derived dendritic cells differentiated in the presence of Interferon-β and Interleukine-3 induce production of Interleukine-17 in mixed lymphocyte reaction via the secretion of Interleukin-23 and Interleukin-6 (2011) (0)
Class II-Disparate Skin Allografts in Mice IL-5 Mediates Eosinophilic Rejection of MHC (1999) (0)
T-cell phenotype and polarization in human abdominal aortic aneurysm (2004) (0)
Inability of OKT3 to prevent donor‐derived ABO hemolytic anemia in a kidney‐pancreas transplant recipient (1995) (0)
Nicotine protects from renal ischemia/reperfusion injury: 12AP5-4 (2007) (0)
Flow cytometric analysis of cytokine production by lymphocytes from two patients with the hypereosinophilic syndrome (HES) (1997) (0)
Materno-fetal interactions in experimental Chagas'disease (1987) (0)
Domain-Independent Mechanism Caspase-8-Dependent , Fas-Associated Death Dendritic Cells : Evidence for a Tumoricidal Activity of Monocyte-Derived (2001) (0)
Interleukln 5 Synthesis by Eosinophils: Association with Granules and Immunoglobulln-dependent Secretion (2003) (0)
Building the future of immunotherapy (2002) (0)
EARLY IMMUNOSUPPRESSION WEANING AFTER CADAVER LIVER TRANSPLANTATION USING ATG INDUCTION AND RAPAMYCIN: 358 (2008) (0)
Suppressor Cells in Superantigen-Induced Respectively as Inducer and Effector T T Cells Act - CD4+CD25+ and CD4+CD25 (2013) (0)
Transplantation tolerance and mixed chimerism: at the frontier of clinical application (1997) (0)
Role of anti-donor Th2-like cells in the autoimmune syndrome occurring in mice made neonatally tolerant to alloantigens (1990) (0)
Biased expansion of memory-type CD8(+) T cells as a cause of acute rejection upon immunosuppression withdrawal in a tolerance pilot trial in liver transplantion (2009) (0)
Persistant Chimerism, Anti-arsonate Response and Immunopathology After Neonatal Induction of Transplantation Tolerance (1985) (0)
Pneumonia after Influenza Infection Enhanced Susceptibility to Pneumococcal IL-10 Is an Important Mediator of the (2004) (0)
Differential effects ofpentoxifylline on theproduction oftumour necrosis factor-alpha (TNF-x)andinterleukin-6 (IL-6) bymonocytesandT cells (1992) (0)
Clonal Lymphocytes in Patients with Idiopathic Hypereosinophilic Syndrome (2004) (0)
182 Differential involvement of IRF members in IL-27 synthesis induced by TLR ligation (2008) (0)
Faculty Opinions recommendation of B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. (2008) (0)
Regulatory T cells (PP-045) (2010) (0)
Hypereosinophilia: Primary and Secondary (2009) (0)
New therapeutic strategies for cell-mediated autoimmune diseases. (1994) (0)
Pathological consequences of idiotypic interactions (1985) (0)
inhibitory role of interferon alpha on the release of mediators Eosinophils express a functional receptor for interferon alpha (2011) (0)

This paper list is powered by the following services:

Other Resources About Michel Goldman

en.wikipedia.org

What Schools Are Affiliated With Michel Goldman?

Michel Goldman is affiliated with the following schools:

Image Attributions

Image Source for Michel Goldman